Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2A

Cary A. Moody(National Center for Tumor Diseases), Rona S. Scott(National Center for Tumor Diseases), Nazanin Amirghahari, Cherie‐Ann O. Nathan(Louisiana State University Health Sciences Center Shreveport), Lawrence S. Young, Chris Dawson, John W. Sixbey(National Center for Tumor Diseases)
Journal of Virology
April 12, 2005
Cited by 120Open Access
Full Text

Abstract

Control of translation initiation is one means by which cells regulate growth and proliferation, with components of the protein-synthesizing machinery having oncogenic potential. Expression of latency protein LMP2A by the human tumor virus Epstein-Barr virus (EBV) activates phosphatidylinositol 3-kinase/Akt located upstream of an essential mediator of growth signals, mTOR (mammalian target of rapamycin). We show that mTOR is activated by expression of LMP2A in carcinoma cells, leading to wortmannin- and rapamycin-sensitive inhibition of the negative regulator of translation, eukaryotic initiation factor 4E-binding protein 1, and increased c-Myc protein translation. Intervention by this DNA tumor virus in cellular translational controls is likely to be an integral component of EBV tumorigenesis.


Related Papers

No related papers found

Powered by citation graph analysis